RCEL250117P2500
- 0.00
- 0.000.00%
Avita Medical Newsroom
Cantor Fitzgerald Bullish on Avita Medical After FDA Approval for RECELL GO Mini
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
Cantor Fitzgerald Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $21
Avita Medical Price Target Maintained With a $21.00/Share by Cantor Fitzgerald
D. Boral Capital Initiates Avita Medical(RCEL.US) With Buy Rating, Announces Target Price $25
D. Boral Capital Initiates Coverage On AVITA Medical With Buy Rating, Announces Price Target of $25
AVITA Medical Analyst Ratings
Biggest Stock Movers Tuesday: X, CYTK, and More
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
Avita Medical Says FDA Approved Recell GO Mini
AVITA Medical Announces FDA Approval of RECELL GO Mini, Optimizing Treatment for Smaller Wounds
Express News | AVITA Medical Announces FDA Approval of Recell Go Mini, Optimizing Treatment for Smaller Wounds
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $20
Lake Street Gives a Buy Rating to Avita Medical (RCEL)
AVITA Medical Gets FDA Clearance for Wound Treatment; Shares Rise After Hours
Express News | AVITA Medical Inc - to Develop Clinical Data for Cohealyx in Early 2025
Express News | AVITA Medical Announces FDA 510(K) Clearance for Cohealyx, Expanding Its Addressable Market
Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
AVITA Medical to Present at the Piper Sandler 36th Annual Healthcare Conference
Express News | AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand